From: Regulatory role of local tissue signal Del-1 in cancer and inflammation: a review
 | Disease or pathophysiological conditions | Roles of Del-1 | Outcomes | Articles |
---|---|---|---|---|
Pro-oncogene s roles | Liver cancer | Plays an important role in the process of tumor cells moving from the primary site | The expression of Del-1 was higher in the human liver hepatocellular carcinoma cell line, tumor cell-EC adhesion was inhibited by antibodies against αvβ3, αvβ5 | Niu et al. [26] |
Breast cancer | A biomarker and a progression predictor | Del-1 are upregulated both in plasma and circulating extracellular vesicles of early-stage breast cancer patients, the sensitivity of Del-1 for early-stage breast cancer diagnosis is higher than in CA-153; Del-1 is correlated with cancer progression and worse survival trend in triple-negative breast cancer | ||
Liver cancer | A poor prognosis predictor | EDIL3 was highly expressed in the HCC patients, Multivariate Cox’s analysis showed that the EDIL3 expression level was a significant and independent prognostic parameter for the overall survival rate of HCC patients | Sun et al. [31] | |
Liver cancer | Enhancing the tumorigenic, metastatic, and angiogenesis potential | Overexpression of EDIL3, which was regulated by the downregulation of miR-137 in HCC, triggered the activation of ERK and TGF-β signaling through interactions with αvβ3 integrin. Blocking ERK and TGF-β signaling overcomes EDIL3 induced angiogenesis and invasion | Xia et al. [32] | |
 | Bone marrow niche | Promoting the proliferation and differentiation of HSCs into myeloid lineage | In the bone marrow niche, Del-1 binds to HSCs αvβ3 integrin on one end and interacts with the extracellular matrix on the other end, thus promoting HSCs proliferation and differentiation into the myeloid lineage | Mitroulis et al. [21], Chen et al. |
Anti-inflammatory roles | Inflammation | Exerting anti-inflammatory effects by inhibiting neutrophil recruitment and migration | In the vessel lumen, endothelial cell-derived Del-1 blocks the binding of αLβ2(LFA-1) integrin on neutrophils to ICAM-1 on vascular endothelial cells, thereby blocking the adhesion and migration of neutrophils | Vestweber et al. [16] |
Inflammation resolution | Accelerating macrophage efferocytosis and inflammation resolution | In the course of the resolution of inflammation, Del-1 connects PS on apoptotic cells at one end to αvβ3 integrin on macrophages at the other end as a bridge of cell-to-cell communication and the uptake of apoptotic cells by macrophages. Del-1 makes the hepatic X receptor-related pathway reprogram macrophages, which transform macrophages into the pro-resolving phenotype | Kourtzelis et al. [9] | |
Periodontitis | Inhibits osteoclastogenesis and protects against inflammatory bone loss | Del-1 inhibited the expression of NFATc1 in a Mac-1 integrin-dependent manner in periodontitis. Del-1 regulated mouse osteoclast differentiation and function, RGD motif, and E1–E3 repeats of Del-1 involved in osteoclast formation and function. Del-1 also protected against inflammatory bone loss in periodontitis mice which Del-1-Fc was a crucial component of | Shin et al. [50] |